
Oncologist

No OPD information available
Colorectal Cancer
Lung Metastases
Pancreatic Cancer
Prostate Cancer
Diarrhea
Esophageal Cancer
Gastrointestinal Stromal Tumor
Hypertension
Islet Cell Transplantation
Liver Cancer
Metastatic Brain Tumor
Pancreaticoduodenectomy
Renal Cell Carcinoma (RCC)
Turcot Syndrome
Jeremy D. Shapiro is a male medical professional who specializes in treating various conditions such as Colorectal Cancer, Lung Metastases, Pancreatic Cancer, Prostate Cancer, Diarrhea, and more. He is known for his expertise in Islet Cell Transplantation, Liver Cancer, and other complex medical issues.
Jeremy D. Shapiro is dedicated to providing the best care for his patients. He uses special skills and treatments to help them fight diseases and improve their health. Patients trust him because he listens to their concerns, explains things clearly, and shows compassion and empathy.
To stay updated with the latest medical knowledge, Jeremy D. Shapiro regularly reads research articles, attends conferences, and collaborates with other experts in the field. This helps him provide the most advanced and effective treatments to his patients.
Jeremy D. Shapiro works closely with his colleagues and other medical professionals to ensure the best outcomes for his patients. He values teamwork, communication, and sharing knowledge to deliver comprehensive care.
Jeremy D. Shapiro's work has made a positive impact on many patients' lives. His research on Machine Learning Models and participation in clinical trials like the study of AM0010 in combination with FOLFOX for metastatic pancreatic cancer have contributed to advancements in cancer treatment and improved survival rates.
In one of his notable publications, Jeremy D. Shapiro discussed how early toxicity trajectories can predict cancer survival, showing his commitment to advancing cancer care. His dedication to research and patient care makes him a respected and trusted healthcare provider in the medical community.
Enrollment Status: Completed
Published: October 19, 2020
Intervention Type: Biological, Drug
Study Drug:
Study Phase: Phase 3
